Nitric oxide synthase

Jump to: navigation, search
The NOS reaction mechanism.
The heme moiety of the enzyme is colored.

WikiDoc Resources for Nitric oxide synthase

Articles

Most recent articles on Nitric oxide synthase

Most cited articles on Nitric oxide synthase

Review articles on Nitric oxide synthase

Articles on Nitric oxide synthase in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Nitric oxide synthase

Images of Nitric oxide synthase

Photos of Nitric oxide synthase

Podcasts & MP3s on Nitric oxide synthase

Videos on Nitric oxide synthase

Evidence Based Medicine

Cochrane Collaboration on Nitric oxide synthase

Bandolier on Nitric oxide synthase

TRIP on Nitric oxide synthase

Clinical Trials

Ongoing Trials on Nitric oxide synthase at Clinical Trials.gov

Trial results on Nitric oxide synthase

Clinical Trials on Nitric oxide synthase at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Nitric oxide synthase

NICE Guidance on Nitric oxide synthase

NHS PRODIGY Guidance

FDA on Nitric oxide synthase

CDC on Nitric oxide synthase

Books

Books on Nitric oxide synthase

News

Nitric oxide synthase in the news

Be alerted to news on Nitric oxide synthase

News trends on Nitric oxide synthase

Commentary

Blogs on Nitric oxide synthase

Definitions

Definitions of Nitric oxide synthase

Patient Resources / Community

Patient resources on Nitric oxide synthase

Discussion groups on Nitric oxide synthase

Patient Handouts on Nitric oxide synthase

Directions to Hospitals Treating Nitric oxide synthase

Risk calculators and risk factors for Nitric oxide synthase

Healthcare Provider Resources

Symptoms of Nitric oxide synthase

Causes & Risk Factors for Nitric oxide synthase

Diagnostic studies for Nitric oxide synthase

Treatment of Nitric oxide synthase

Continuing Medical Education (CME)

CME Programs on Nitric oxide synthase

International

Nitric oxide synthase en Espanol

Nitric oxide synthase en Francais

Business

Nitric oxide synthase in the Marketplace

Patents on Nitric oxide synthase

Experimental / Informatics

List of terms related to Nitric oxide synthase


Overview

The nitric oxide synthase (NOS; EC 1.14.13.39) is an enzyme in the body that contributes to transmission from one neuron to another, to the immune system and to dilating blood vessels. It does so by synthesis of nitric oxide (NO) from the terminal nitrogen atom of L-arginine in the presence of NADPH and dioxygen (O2). NOS is the only known enzyme that binds flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), heme, tetrahydrobiopterin (BH4) and calmodulin. NOS activates Cyclic GMP, which induces smooth muscle relaxation by multiple mechanisms including: 1. increased intracellular cGMP, which inhibits calcium entry into the cell, and decreases intracellular calcium concentrations 2. activates K+ channels, which leads to hyperpolarization and relaxation 3. stimulates a cGMP-dependent protein kinase that activates myosin light chain phosphatase, the enzyme that dephosphorylates myosin light chains, which leads to smooth muscle relaxation.

Classification

NOS was first identified by Furchgott (1980) who experimented on the aortas of rabbits.[1] Since then, the different forms of NO synthase have been classified as follows:

Name Gene(s) Location Function
Neuronal NOS (nNOS or NOS1) NOS1
  • cell communication
Inducible NOS (iNOS or NOS2) NOS2A, NOS2B, NOS2C
  • immune defence against pathogens
Endothelial NOS (eNOS or NOS3 or cNOS) NOS3

nNOS

Neuronal NOS (nNOS) produces NO in nervous tissue in both the central and peripheral nervous system. Neuronal NOS also performs a role in cell communication and is associated with plasma membranes. nNOS action can be inhibited by NPA (N-propyl-L-arginine).

iNOS

Inducible NOS (iNOS) can be found in the immune system but is also found in the cardiovascular system. It uses the oxidative stress of NO (a free radical) to be used by macrophages in immune defence against pathogens.

eNOS

Endothelial NOS (eNOS), also known as nitric oxide synthase 3 (NOS3) or constitutive NOS (cNOS), generates NO in blood vessels and is involved with regulating vascular function. A constitutive Ca2+ dependent NOS provides a basal release of NO. eNOS is associated with plasma membranes surrounding cells and the membranes of Golgi bodies within cells.

Chemical reaction

Nitric oxide synthase produces NO by catalysing a five-electron oxidation of a guanidino nitrogen of L-arginine (L-Arg). Oxidation of L-Arg to L-citrulline occurs via two successive monooxygenation reactions producing Nω-hydroxy-L-arginine (NOHLA) as an intermediate. 2 mol of O2 and 1.5 mol of NADPH are consumed per mole of NO formed.

L-Arg + NADPH + H+ + O2 → NOHLA + NADP+ + H2O
NOHLA + ½ NADPH + ½ H+ + O2L-citrulline + ½ NADP+ + NO + H2O

Structure

All three isoforms (each of which is presumed to function as a homodimer during activation) share a carboxyl-terminal reductase domain homologous to the cytochrome P450 reductase. They also share an amino-terminal oxygenase domain containing a heme prosthetic group, which is linked in the middle of the protein to a calmodulin-binding domain. Binding of calmodulin appears to act as a "molecular switch" to enable electron flow from flavin prosthetic groups in the reductase domain to heme. This facilitates the conversion of O2 and L-arginine to NO and L-citrulline. The oxygenase domain of each NOS isoform also contains an BH4 prosthetic group, which is required for the efficient generation of NO. Unlike other enzymes where BH4 is used as a source of reducing equivalents and is recycled by dihydrobiopterin reductase (EC 1.5.1.33), BH4 activates heme-bound O2 by donating a single electron, which is then recaptured to enable nitric oxide release.

The first nitric oxide synthase to be identified was found in neuronal tissue (NOS1 or nNOS); the endothelial NOS (eNOS or NOS3) was the third to be identified. They were originally classified as "constituitvely expressed" and "Ca2+ sensitive" but it is now known that they are present in many different cell types and that expression is regulated under specific physiological conditions.

In NOS1 and NOS3, physiological concentrations of Ca2+ in cells regulate the binding of calmodulin to the "latch domains", thereby initiating electron transfer from the flavins to the heme moieties. In contrast, calmodulin remains tightly bound to the inducible and Ca2+-insensitive isoform (iNOS or NOS2) even at a low intracellular Ca2+ activity, acting essentially as a subunit of this isoform.

Nitric oxide may itself regulate NOS expression and activity. Specifically, NO has been shown to play an important negative feedback regulatory role on NOS3, and therefore vascular endothelial cell function. This process, known formally as S-nitrosation (and referred to by many in the field as S-nitrosylation), has been shown to reversibly inhibit NOS3 activity in vascular endothelial cells. This process may be important because it is regulated by cellular redox conditions and may thereby provide a mechanism for the association between "oxidative stress" and endothelial dysfunction. In addition to NOS3, both NOS1 and NOS2 have been found to be S-nitrosated, but the evidence for dynamic regulation of those NOS isoforms by this process is less complete. In addition, both NOS1 and NOS2 have been shown to form ferrous-nitrosyl complexes in their heme prosthetic groups that may act partially to self-inactivate these enzymes under certain conditions. The rate-limiting step for the production of nitric oxide may well be the availability of L-arginine in some cell types. This may be particularly important after the induction of NOS2.

References

  1. Furchgott R, Zawadzki J (1980). "The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine". Nature. 288 (5789): 373–6. PMID 6253831.

External links



Linked-in.jpg